Nasal Drug Delivery
Gain an Edge in Your Nasal Market
Millions of people suffer from allergic rhinitis. Yet current treatments are often limited to aqueous nasal sprays. These sprays can drip down the throat and out of the nose, causing irritation, embarrassment, and unpleasant aftertastes. Improving the patient experience can go a long way toward improving your bottom line. 3M can help. With intuitive patient-friendly nasal MDIs, our innovations can enable your treatments to stay on the cutting edge while making life better for patients.
Contact Us »
The Edge is Delivering Patient Preference
Featuring a no-drip aerosol delivery, the 3M™ Nasal MDI eliminates post-nasal drip and doesn't leave an aftertaste. The sleek, ergonomic design is easy to administer and discreet enough to be used comfortably in public. With accurate, metered dosing, patients can be confident that each dose was delivered. Plus, the optional dose counter shows how much is left and when it's time to replace the device.
The Edge is a Differentiated Device
3M™ Nasal MDI technology is ideal for partners wanting a rapid, cost-effective extension of their inhaled corticosteroid or for those seeking a device edge for new nasal treatments. Designed to be technically superior and more patient-friendly than aqueous nasal spray systems, our nasal MDI device incorporates reliable 3M pulmonary MDI technology and has a twist-and-lock cover to improve hygiene. Plus, the device is metered for accurate dosing, and it's compatible with existing valves and our proprietary dose counter.
3M™ Nasal MDI technology is Ideal for:
- Lifecycle management of off-patent allergic rhinitis products
- New combination treatments that target nasal allergies (e.g., steroids + antihistamines)
- Fast line extension for inhaled corticosteroids
- Pipeline allergy molecules
- Nasal delivery of molecules to by-pass the blood-brain barrier
The Edge is having a Pioneering Partner
You want a partner that can overcome the technical challenges you'll face with solutions based on rigorous science. As inventors of both the very first and the latest MDIs, including nasal HFA formulations, we can leverage our 50 years of experience to take the risk out of commercializing your innovation. Count on our experienced global manufacturing team to bring your specialized nasal MDI solution from formula development and clinical trials to commercial delivery and scale up.
- Expertise in customizing solutions to fit drug formulation needs
- Global regulatory compliance & toxicology support
- Secure supply chain with global compliance & distribution
- Nasal MDI production does not require an aseptic manufacturing environment
- Incorporates high-quality, reliable 3M MDI components
We ask better questions, to provide leaner solutions, to get you to market faster.
Take the First Step
3M has over five decades of proven success in MDI development, manufacture and delivery to market. Contact us to receive an initial, cost-free paper feasibility assessment and to begin partnering with us to commercialize your nasal MDI innovation.
Contact Us »
Related Posters, Presentations and Publications
Inhalation Drug Delivery: Product Differentiation in an Ever-Shifting Inhalation Landscape (1.14 mb, PDF)
Moving Toward Patient-Preferred Nasal Drug Delivery (1.77 mb, PDF)
Nasal Inhaler Information Sheet (283 kb, PDF)
Bringing the Patient's Voice to Nasal Drug Delivery (2 mb, PDF)
POSTER: Rapid Development of a Patient-Preferred Nasal pMDI Device (1.50 mb, PDF)